1352419-24-9

Basic information

• Product Name: (R)-5-(3-bromophenyl)-5-methyl-5,6-dihydro-2H-1,4-oxazin-3-amine
• Synonyms: (R)-5-(3-bromophenyl)-5-methyl-5,6-dihydro-2H-1,4-oxazin-3-amine
• CAS NO: 1352419-24-9
• Molecular Weight: 269.141
• Mol File: 1352419-24-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (R)-5-(3-bromophenyl)-5-methyl-5,6-dihydro-2H-1,4-oxazin-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-5-(3-bromophenyl)-5-methyl-5,6-dihydro-2H-1,4-oxazin-3-amine(1352419-24-9)
• EPA Substance Registry System: (R)-5-(3-bromophenyl)-5-methyl-5,6-dihydro-2H-1,4-oxazin-3-amine(1352419-24-9)

Safety Data

• Hazardous Substances Data: 1352419-24-9(Hazardous Substances Data)

Upstream product

• 7399-36-2 rac-2-amino-2-(3-bromophenyl)-propionic acid 
• 1266784-04-6 (R)-(+)-N-[1-(3-bromo-phenyl)-2-hydroxy-1-methyl-ethyl]-2-chloro-acetamide 
• 1394137-79-1 (S)-N-((R)-2-(3-bromophenyl)-1-(tert-butyldiphenylsilyloxy)propan-2-yl)-2-methylpropane-2-sulfinamide 
• 1352419-23-8 (5R)-5-(3-bromophenyl)-5-methylmorpholine-3-thione 
• 1213181-85-1 (2R)-2-amino-2-(3-bromophenyl)-propan-1-ol 
• 1266785-37-8 (5R)-5-(3-bromophenyl)-5-methyl-morpholin-3-one 
• 1183581-39-6 (RS)-2-amino-2-(3-bromo-phenyl)-propionic acid methyl ester 
• 1183013-69-5 (RS)-2-amino-2-(3-bromo-phenyl)-propan-1-ol 
• 953741-63-4 rac-2-amino-2-(3-bromo-phenyl)-propionitrile 
• 2142-63-4 1-(3-Bromophenyl)ethanone 

Downstream Products

• 1266786-47-3 N-{3-[(3R)-5-amino-3-methyl-3,6-dihydro-2H-1,4-oxazin-3-yl]phenyl}-5-chloropyridine-2-carboxamide 
• 1352419-25-0 (5R)-5-(3-aminophenyl)-5-methyl-5,6-dihydro-2H-1,4-oxazin-3-amine 
• 1394137-71-3 (R)-5-[3-(benzhydrylideneamino)phenyl]-5-methyl-2,6-dihydro-2H-1,4-oxazin-3-amine 

Relevant articles and documents

1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads

1,4-Oxazines are presented, which show good in vitro inhibition in enzymatic and cellular BACE1 assays. We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site. Our strategy permi

5,6-DIHYDRO-2H-[1,4]OXAZIN-3-YL-AMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

The present invention relates to novel 5,6-dihydro-2H-[1,4]oxazin-3-ylamine derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease and dementia associated with beta- amyloid.